Natural Product: NPC76938

Natural Product IDNPC76938
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
3-(10-Phenyldecyl)Phenol
IUPAC Name 3-(10-phenyldecyl)phenol
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL477541
PubChem CID 44575633
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000134] Phenols
        • [CHEMONTID:0004647] 1-hydroxy-4-unsubstituted benzenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey RZNASAROZKRKEJ-UHFFFAOYSA-N
Standard InCHI InChI=1S/C22H30O/c23-22-18-12-17-21(19-22)16-9-6-4-2-1-3-5-8-13-20-14-10-7-11-15-20/h7,10-12,14-15,17-19,23H,1-6,8-9,13,16H2
SMILES Oc1cccc(c1)CCCCCCCCCCc1ccccc1

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   310.23 Volume:   364.927
?
Van der Waals volume.
Dense:   0.85 LogP:   6.093
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.9
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.446
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   11.0 Rigid Bonds:   12.0
TPSA:   20.23
?
Topological Polar Surface Area.
H-Bond Acceptor:   1.0
H-Bond Donor:   1.0 Rings:   2.0
Heavy Atoms:   1.0

MedChem Properties

QED Drug-Likeness Score:   0.483 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   1.723 Fsp3:   0.455
MCE-18:   9.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.856 Fluc inhibitor:   0.344
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.007
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.162
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.868 Promiscuous compounds:   0.092

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.087 MDCK Permeability:   -4.767
Pgp-inhibitor:   0.969 Pgp-substrate:   0.026
PAMPA:   0.01
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.074
20% Bioavailability (F20%):   0.795 30% Bioavailability (F30%):   0.987
50% Bioavailability (F50%):   0.975

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.213 MRP1:   0.274
Plasma Protein Binding (PPB):   100.5% Volume Distribution (VD):   1.111
Fu: 0.103%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.964
OATP1B3 inhibitor:   0.99 BCRP inhibitor:   0.768
BSEP inhibitor:   0.999

ADMET: Metabolism

CYP1A2-inhibitor:   0.342 CYP1A2-substrate:   0.987
CYP2C19-inhibitor:   0.168 CYP2C19-substrate:   0.775
CYP2C9-inhibitor:   0.919 CYP2C9-substrate:   0.911
CYP2D6-inhibitor:   0.84 CYP2D6-substrate:   0.343
CYP3A4-inhibitor:   0.275 CYP3A4-substrate:   0.998
CYP2B6-substrate:   0.783 CYP2C8-inhibitor:   0.98
HLM stability:   0.91
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  4.771 Half-life (T1/2):  0.338

ADMET: Toxicity

hERG Blockers:  0.822 hERG Blockers (10um):  0.933
Human Hepatotoxicity (H-HT):  0.565 Drug-induced Liver Injury (DILI):  0.129
AMES Toxicity:  0.161 Rat Oral Acute Toxicity:  0.17
Maximum Recommended Daily Dose:  0.366 Skin Sensitization:  0.973
Carcinogencity:  0.14 Eye Corrosion:  0.747
Eye Irritation:  0.993 Respiratory Toxicity:  0.79
Drug-induced Neurotoxicity:  0.3 Ototoxicity:  0.173
Hematotoxicity:  0.101 Drug-induced Nephrotoxicity:  0.31
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.051
A549 Cytotoxicity:  0.807 Hek293 Cytotoxicity:  0.725
BCF:   1.743
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.405
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.289
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   6.441
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11253 Knema glomerata Species Myristicaceae Eukaryota n.a. n.a. n.a. PMID[8201311]
NPO11253 Knema glomerata Species Myristicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell line A549 Homo sapiens ED50 = 35.01 ug ml-1 PMID[25630222]
NPT83 Cell line MCF7 Homo sapiens ED50 = 7.76 ug ml-1 PMID[20843939]
NPT139 Cell line HT-29 Homo sapiens ED50 = 28.59 ug ml-1 PMID[18157122]
NPT141 Organism Agrobacterium tumefaciens Agrobacterium tumefaciens T/C = 54.0 % PMID[8201311]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference
- Artemia LC50 = 0.45 ug.mL-1 PMID[26465972]

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC76938 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC32714
0.8182 Intermediate Similarity NPC3358
0.8182 Intermediate Similarity NPC306884
0.8182 Intermediate Similarity NPC603092
0.7647 Intermediate Similarity NPC241891
0.7647 Intermediate Similarity NPC134829
0.725 Intermediate Similarity NPC294741
0.7105 Intermediate Similarity NPC483454
0.7105 Intermediate Similarity NPC162314
0.697 Remote Similarity NPC610566
0.6923 Remote Similarity NPC94139
0.6923 Remote Similarity NPC147284
0.6429 Remote Similarity NPC210497
0.6429 Remote Similarity NPC192
0.641 Remote Similarity NPC487734
0.6364 Remote Similarity NPC606762
0.625 Remote Similarity NPC487735
0.6061 Remote Similarity NPC210849
0.5882 Remote Similarity NPC246056
0.5882 Remote Similarity NPC609251
0.5833 Remote Similarity NPC123273
0.5833 Remote Similarity NPC318325
0.5778 Remote Similarity NPC259942
0.5778 Remote Similarity NPC92624
0.5625 Remote Similarity NPC27974
0.5556 Remote Similarity NPC606008
0.55 Remote Similarity NPC474839
0.5455 Remote Similarity NPC188814
0.5455 Remote Similarity NPC599916
0.5455 Remote Similarity NPC608141
0.5405 Remote Similarity NPC294186
0.5405 Remote Similarity NPC147310
0.5405 Remote Similarity NPC137415
0.5405 Remote Similarity NPC166313
0.5405 Remote Similarity NPC192032
0.5405 Remote Similarity NPC24407
0.5405 Remote Similarity NPC11280
0.5278 Remote Similarity NPC242240

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC76938 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data